The global brokerage firm maintained its ‘Buy’ call for Fortis Healthcare with an updated twelve month forward target price of Rs 547, a 12 per cent upside to Monday’s close
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
